Join President Sandoval and Professor Geoffrey Blewitt as they discuss the science of geodesy, the ways in which GPS impact ...
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback